| Stage | NVDA | % of rev | TSLA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $96.2B | 100.00% | $28.0B | 100.00% | NVDA ×3.43 |
| Gross profit | $72.1B | 74.98% | $5.5B | 19.59% | NVDA +55.4pp |
| Operating income | $63.7B | 66.24% | $718M | 2.56% | NVDA +63.7pp |
| Pre-tax income | $71.5B | 74.32% | $956M | 3.41% | NVDA +70.9pp |
| Net income | $59.7B | 62.03% | $804M | 2.87% | NVDA +59.2pp |
| Stage | NVDA | TSLA | Gap · A − B |
|---|---|---|---|
| Revenue | $96.2B100.00% | $28.0B100.00% | NVDA ×3.43 |
| Gross profit | 74.98%$72.1B | 19.59%$5.5B | NVDA +55.4pp |
| Operating income | 66.24%$63.7B | 2.56%$718M | NVDA +63.7pp |
| Pre-tax income | 74.32%$71.5B | 3.41%$956M | NVDA +70.9pp |
| Net income |
| 62.03%$59.7B |
| 2.87%$804M |
| NVDA +59.2pp |
No shared counterparties.